INGN-225: a dendritic cell-based p53 vaccine (Ad.p53-DC) in small cell lung cancer: observed association between immune response and enhanced chemotherapy effect

IMPORTANCE OF THE FIELD: Novel approaches are needed for patients with small cell lung cancer (SCLC), as response after relapse is poor with standard therapies. p53 gene mutations often occur, resulting in tumoral protein overexpression and allowing for their recognition by p53-specific cytotoxic T...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Chiappori, Alberto A, Soliman, Hatem, Janssen, William E, Antonia, Scott J, Gabrilovich, Dmitry I
Format: Artigo
Langue:Inglês
Publié: 2010
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3146364/
https://ncbi.nlm.nih.gov/pubmed/20420527
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14712598.2010.484801
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires